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Paratuberculosis is a chronic infectious disorder and a major problem in farmed ruminants. This
disease is caused by Mycobacterium avium subsp. paratuberculosis. M. avium subsp. paratuberculosis is an
important pathogen that causes Johne’s disease in animals and also has been implicated as a possible
cause of Crohn’s disease in humans, but little is known about the protective immune responses to this
microorganism. Fibronectin attachment protein (FAP) is a member of a family of fibronectin-binding
proteins produced by several species of mycobacteria which is important in the pathogenesis of M. avium.
Addition of recombinant FAP to human respiratory tract organ cultures inhibits M. avium binding to areas
where there is epithelial damage. We characterized the role of FAP in promoting adaptive and innate
immune responses. FAP functionally activated dendritic cells by augmenting the expression of CD80,
CD86, major histocompatibility complex class I, and major histocompatibility complex class II. Moreover,
FAP induced the allogeneic immunostimulatory capacity of dendritic cells by stimulating dendritic cell
production of Th1-promoting interleukin-12. FAP also increased the production of gamma interferon by
T cells in mixed-lymphocyte reactions, which would be expected to contribute to the Th1 polarization of
the immune response. The expression of surface markers and cytokine production in dendritic cells was
mediated by both mitogen-activated protein kinases and NF-B pathways. These results show that FAP
modulates the adaptive immune responses to M. avium subsp. paratuberculosis by inducing maturation and
activation of dendritic cells, which drives Th1 polarization.
Dendritic cells (DCs) are professional antigen-presenting
cells (APCs) that play key roles in the regulation of immune
responses to a variety of antigens (26, 34). Immature DCs are
distributed mainly in tissues interfacing with the external en-
vironment, where they capture and process antigens with high
efficiency (3, 7). Immature DCs in peripheral tissues capture
and process exogenous agents which trigger DC maturation
(35). Maturing DCs then migrate into the lymphoid organs,
where they activate naïve T cells by stimulating antigenic pep-
tide-presenting major histocompatibility complex (MHC) type
I and II receptors and their costimulatory molecules (27).
Stimulation of these receptors activates mitogen-activated pro-
tein kinases (MAPKs) and transcription nuclear factor B
(NF-B), which regulates the maturation and differentiation of
the DCs (14). In this manner, as part of the innate immune
response, when DCs encounter microbes and their products in
the tissues that interface with the external environment, they
produce proinflammatory cytokines that activate lymphocytes
to directly kill infected cells (19, 33). Thus, DCs provide a link
between the innate and adaptive immune responses (4).
Paratuberculosis, or Johne’s disease, is a chronic granulo-
matous enteritis of domestic and wild ruminants that is caused
by Mycobacterium avium subsp. paratuberculosis (31). This
slow-growing, acid-fast bacillus invades macrophages in lym-
phoid tissue of the ileum, where it induces recruitment of
inflammatory cells, suppresses phagosome maturation, and re-
sults in granulomatous enteritis (30). The granulomas cause
the intestinal villi to become distorted and lose absorptive
surface area. M. avium subsp. paratuberculosis enters intestinal
tissue via M cells, which are found in the dome covering Pey-
er’s patches (21). Attachment and internalization of M. avium
subsp. paratuberculosis by epithelial cells have been shown to
be dependent on the interaction between fibronectin attach-
ment proteins (FAPs) and fibronectin (28, 29). The FAPs are
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a family of fibronectin-binding proteins that are present in
several species of mycobacteria (36). Addition of recombinant
FAP inhibits M. avium binding to extracellular matrix in areas
where there is epithelial damage, demonstrating the impor-
tance of FAP in M. avium pathogenesis (30). Recently, it was
reported that human DCs infected with virulent M. avium
exhibited limited and reversible upregulation of maturation
markers, including CD80, CD86, and CD40. M. avium-infected
DCs induced low levels of allogeneic lymphocyte proliferation,
CD8 T-cell activation, and memory CD4 T-cell activation
compared with in vitro mature DCs (8, 15). The level of iden-
tity between the FAPs of M. avium and M. avium subsp. para-
tuberculosis was 96%.
However, it is not known if hosts mount protective immune
responses against FAP of M. avium subsp. paratuberculosis.
Understanding how the immune system responds to FAP is
critical for the development of an effective M. avium subsp.
paratuberculosis vaccine.
In this study, we investigated the effects of a noncytotoxic
concentration of FAP on the maturation and function of DCs.
Our findings demonstrated for the first time that exposure to
FAP induces phenotypic and functional maturation of DCs.
Exposure to FAP also induced the activation of extracellular
signal-regulated kinase 1/2 (ERK1/2) and p38 MAPK and
NF-B nuclear translocation, similar to exposure to lipopoly-
saccharide (LPS). Our data also suggest that FAP induced
activation of DCs and initiated the adaptive immune response
by polarizing T-cell development to a Th1 response. The crit-
ical role of FAP in the activation of these professional APCs
and in the immune response to M. avium subsp. paratubercu-
losis suggests that FAP may be exploited for development of an
M. avium subsp. paratuberculosis vaccine.
MATERIALS AND METHODS
Animals. Male 8- to 12-week-old C57BL/6 (H-2Kb and I-Ab) and BALB/c
(H-2Kd and I-Ad) mice were purchased from the Korean Institute of Chemistry
Technology (Daejeon, South Korea). They were housed in a pathogen-free
environment in our animal facility for at least 1 week before use.
Reagents and antibodies. Recombinant mouse granulocyte-macrophage colony-
stimulating factor (GM-CSF) and recombinant mouse interleukin-4 (IL-4)
were purchased from R&D Systems (Minneapolis, MN). Dextran-fluorescein
isothiocyanate (FITC) (molecular mass, 40,000 Da) and LPS (from Escherichia
coli O55:B5) were obtained from Sigma-Aldrich (St. Louis, MO). An endotoxin
filter (END-X) and an endotoxin removal resin (END-X B15) were acquired
from Associates of Cape Cod (East Falmouth, MA). Cytokine enzyme-linked
immunosorbent assay (ELISA) kits for murine IL-12p70, IL-4, and gamma
interferon (IFN-) were purchased from BD PharMingen (San Jose, CA). FITC-
or phycoerythrin (PE)-conjugated monoclonal antibodies (MAbs) were used for
flow cytometry to detect antibodies (Table 1). To determine protein levels by
Western blotting, anti-phospho-ERK, anti-ERK, anti-phospho-p38, and anti-p38
antibodies were obtained from Cell Signaling (Danvers, MA). Anti-Topo I an-
tibody was obtained from Santa Cruz Biotechnology, (Santa Cruz, CA). Anti-p65
antibody was obtained from Abcam (Cambridge, MA).
Generation and culture of DCs. DCs were generated from murine whole bone
marrow cells. Briefly, bone marrow was flushed from the tibiae and femurs of
C57BL/6 mice, and red blood cells were depleted with ammonium chloride. The
cells were plated in six-well culture plates (106 cells/ml, 3 ml/well) and cultured
at 37°C in the presence of 5% CO2 using OptiMEM (Invitrogen Life Technol-
ogies, Carlsbad, CA) supplemented with 10% heat-inactivated fetal bovine se-
rum (FBS), 2 mM L-glutamine, 100 U/ml penicillin, 100 g/ml streptomycin, 5 
105 M -mercaptoethanol, 10 mM HEPES (pH 7.4), 20 ng/ml recombinant
mouse GM-CSF, and 20 ng/ml recombinant mouse IL-4. On day 3 of culture,
floating cells were gently removed, and fresh medium was added. On day 6 or 7
of culture, nonadherent cells and loosely adherent proliferating DC aggregates
were harvested for analysis or stimulation, or in some experiments they were
replated into 60-mm dishes (106 cells/ml, 5 ml/dish). On day 6, 80% or more of
the nonadherent cells expressed CD11c. To obtain highly purified populations
for subsequent analyses, the DCs were labeled with bead-conjugated anti-CD11c
MAb (Miltenyi Biotec, Bergisch Gladbach, Germany), followed by positive se-
lection on paramagnetic columns (LS columns; Miltenyi Biotec, Bergisch Glad-
bach, Germany) according to the manufacturer’s instructions. The purity of the
cell fraction selected was 95%.
Bacterial strains and culture conditions. M. avium subsp. paratuberculosis
JTC303 was grown at 37°C in modified 7H9 broth supplemented with 10%
(vol/vol) oleic acid-albumin-dextrose-catalase (Becton Dickinson, Sparks, MD)
and 2 g/ml of mycobactin J (Allied Monitor, Fayette, MO) for 1 month as
previously described. Both E. coli BL21(DE3), purchased from Novagen (Mad-
ison, WI), and E. coli DH5	 were grown at 37°C in Luria broth (FisherBiotech,
Fair Lawn, NJ). After plasmid transformation, E. coli was cultured in Luria broth
containing ampicillin (100 g/ml).
Plasmid and vector construction. The cloning vector plasmid pGEM-T Easy
was purchased from Promega (Madison, WI), and the expression vector pET-
22b() was purchased from Novagen (Madison, WI). Both plasmids contained
TABLE 1. Antibodies used in this study
Antibody Host animal Dilution Companya
Annexin V-FITC Mouse (apoptosis marker) 1:100 BD Pharmingen
Anti-CD11c (N418) Mouse (DC marker) 1:100 BD Pharmingen
CD11c (HL3)-FITC Mouse (DC marker) 1:100 BD Pharmingen
CD11c (HL3)-PE Mouse (DC marker) 1:100 BD Pharmingen
CD4 (L3T4)-FITC Mouse (T-cell marker) 1:100 BD Pharmingen
CD40 (1C10)-PE Mouse (DC activation marker) 1:100 BD Pharmingen
CD80 (16-10A1)-PE Mouse (DC activation marker) 1:100 BD Pharmingen
CD86 (GL1)-PE Mouse (DC activation marker) 1:100 BD Pharmingen
IAb -chain (AF-120.1)-PE Mouse (DC activation marker) 1:100 BD Pharmingen
IL-10 (JESS-16E3)-FITC Mouse (Th2 marker) 1:100 BD Pharmingen
IL-12p40/p70 (C15.6)-PE Mouse (Th1 marker) 1:100 BD Pharmingen
H2Kb (AF6-88.5)-PE Mouse (DC activation marker) 1:100 BD Pharmingen
p-ERK1/2 Mouse (signal marker) 1:1,000 Cell Signaling
ERK1/2 Mouse (signal marker) 1:2,000 Cell Signaling
p-p38 Mouse (signal marker) 1:1,000 Cell Signaling
p38 Mouse (signal marker) 1:2,000 Cell Signaling
Topo I (C-15) Mouse (nucleus protein marker) 1:2,000 Santa Cruz
p-65 Mouse (signal marker) 1:500 Abcam
a BD Pharmingen, BD Pharmingen, San Jose, CA; Cell Signaling, Cell Signaling, Danvers, MA; Santa Cruz, Santa Cruz Biotechnology, Santa Cruz, CA; Abcam,
Abcam, Cambridge, MA.
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an ampicillin resistance marker. The expression vector contained a T7 promoter
and a C-terminal six-His tag-encoding sequence.
Expression and purification of recombinant FAP. Preparation of recombinant
FAP has been described previously (5). Briefly, genomic DNA was isolated from
the M. avium subsp. paratuberculosis JTC303 strain, and the DNA encoding FAP
(MAP1569) (http://www.ncbi.nlm.nih.gov) lacking the signal sequence was am-
plified by PCR. After purification of the PCR product, it was ligated into the
pET-22b() vector digested with the NdeI and XhoI enzymes. Expression of
FAP in transformed BL21(DE3) cells was induced with isopropyl-beta-D-thio-
galactopyranoside (IPTG) (Promega, Madison, WI). The soluble FAP was ex-
tracted after cell disruption by sonication. FAP containing a C-terminal histidine
tag was purified using Ni-nitrilotriacetic acid (NTA) resin (Qiagen, Chatsworth,
CA). The FAP was dialyzed five times in 10 mM phosphate-buffered saline (PBS)
(pH 7.2) using a Slide-A-Lyzer dialysis cassette with a 3-kDa cutoff (Pierce,
Rockford, IL). After dialysis, contaminating endotoxin was removed using De-
toxi-Gel Affinity Pak columns (Pierce, Rockford, IL). FAP was incubated with
endotoxin removal resin overnight to remove LPS and concentrated with a
Centricon device (2,000-Da cutoff; Millipore). Also, endotoxin was assayed un-
der endotoxin-free experimental conditions using a Limulus amebocyte lysate
pyrogen kit (Biowhittaker, Walkersville, MD). The experiments were conducted
according to the manufacturer’s protocol. The quantity of endotoxin in the FAP
was 0.01 ng/mg. The final concentration of purified FAP was determined using
a bicinchoninic acid protein assay kit (Pierce, Rockford, IL).
Stimulation of DC by FAP. FAP was dissolved in culture medium and was
added to cultures of isolated DCs in six-well plates (106 cells/ml, 2 ml/well). For
analysis of apoptosis, DCs were stimulated with LPS in medium or with medium
alone, and apoptosis was analyzed over time by staining surface-exposed phos-
phatidylserine with FITC-annexin V in combination with propidium iodine (PI)
(BD PharMingen, San Jose, CA) according to the manufacturer’s instructions.
Flow cytometric analysis. On day 6, bone marrow DCs were harvested, washed
with PBS, and resuspended in fluorescence-activated cell sorter washing buffer
(2% FBS and 0.1% sodium azide in PBS). Cells were first blocked with 10%
(vol/vol) normal goat serum for 15 min at 4°C and stained with PE-conjugated
anti-H-2Kb (MHC class I), anti-I-Ab (MHC class II), anti-CD40, anti-CD80, and
anti-CD86 along with FITC-conjugated anti-CD11c (PharMingen, San Diego,
CA) for 30 min at 4°C. The stained cells were analyzed using a FACSCalibur flow
cytometer (Becton Dickinson, San Jose, CA).
Quantitation of antigen uptake. Endocytosis was quantitated as described by
Lutz et al. (17). In brief, 2 105 cells were equilibrated at 37°C or 4°C for 45 min
and then pulsed with fluorescein-conjugated dextran (molecular mass, 40,000
Da; Sigma-Aldrich) at a concentration of 1 mg/ml. Cold staining buffer was
added to stop the reaction. The cells were washed three times, stained with
PE-conjugated anti-CD11c antibodies, and then analyzed with the FACSCalibur.
Nonspecific binding of dextran to DCs was determined by incubation of DCs with
FITC-conjugated dextran at 4°C, and the resulting background value was sub-
tracted from the specific binding values. The medium used for the cultures with
FAP stimulation was supplemented with GM-CSF, which is required for the
capture of antigens by DCs.
Cytokine assays. Cells were first blocked with 10% (vol/vol) normal goat
serum for 15 min at 4°C and then stained with FITC-conjugated CD11c anti-
body for 30 min at 4°C. Cells stained with the appropriate isotype-matched
immunoglobulin (Ig) were used as negative controls. The cells were fixed and
permeabilized with a Cytofix/Cytoperm kit (PharMingen, San Jose, CA) used
according to the manufacturer’s instructions. Intracellular IL-12p40/p70, IL-10,
and IFN- were detected with fluorescein R-PE-conjugated antibodies (Phar-
Mingen) in a permeation buffer. The cells were analyzed with a FACSCalibur
flow cytometer using the CellQuest program. The presence of murine IL-12p70,
IL-4, and IFN- in DCs was determined using an ELISA kit (PharMingen, San
Jose, CA) according to the manufacturer’s instructions.
Mixed-lymphocyte reaction. Responder T cells, which participate in allogeneic
T-cell reactions, were isolated using a MACS column from total mononuclear
cells prepared from BALB/c mice (Miltenyi Biotec, Bergisch Gladbach, Ger-
many). Staining with FITC-conjugated anti-CD3 antibodies (BD PharMingen,
San Diego, CA) revealed that the preparation consisted mainly of CD3 cells
(95%). The lymphocyte population (95% CD3 cells) was then washed twice
in PBS and labeled with 5 M carboxyfluorescein succinimidyl ester (CFSE) in
PBS as previously described (19). After they were shaken for 8 min at room
temperature, the cells were washed once in FBS and twice in PBS with 10% FBS.
Unstimulated DCs (1  104 cells) or DCs exposed to FAP (200 ng/ml) or LPS
(200 ng/ml) for 24 h were cocultured with 1  105 allogeneic CFSE-labeled T
lymphocytes in 96-well, U-bottom plates (Nunc, Thermo Fisher Scientific, Roch-
ester, NY). A negative control (CD3 lymphocytes alone) and a positive control
(CD3 lymphocytes with 5 g of concanavalin A) were included in each exper-
iment. After 4 days, the cells were harvested and washed in PBS. Lymphocytes
optically gated by CFSE dilution were assessed by flow cytometry.
Nuclear and cytoplasmic extracts and Western blotting. The cells were pre-
treated with 200 ng/ml FAP. Then following 15 or 30 min of incubation at 37°C,
cells were washed twice with cold PBS and lysed with modified RIPA buffer
(1.0% NP-40, 1.0% sodium deoxycholate, 150 nM NaCl, 10 mM Tris-HCl [pH
7.5], 5.0 mM sodium pyrophosphate, 1.0 mM NaVO4, 5.0 mM NaF, 10 mM/ml
leupeptin, 0.1 mM phenylmethylsulfonyl fluoride) for 15 min at 4°C. Lysates
were cleared by centrifugation at 14,000  g for 20 min at 4°C. The protein
content of cell lysates was determined using a micro bicinchoninic acid assay kit
(Pierce, Rockford, IL). Equivalent amounts of proteins were separated by 10%
or 12% sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE)
and analyzed by Western blotting using anti-phospho-ERK1/2, anti-phospho-c-
Jun N-terminal kinase, or anti-phospho-p38 MAPK MAb for 3 h, as described by
the manufacturers. Following three washes with Tris-buffered saline with Tween,
membranes were incubated with secondary horseradish peroxidase-conjugated
anti-mouse IgG for 1 h. After the blots were washed, they were developed using
the enhanced chemiluminescence system by following the manufacturer’s in-
structions. DC nuclear extracts were prepared using NE-PER nuclear and cyto-
plasmic extraction reagents (Pierce, Rockford, IL) according to the manufactur-
er’s instructions. NF-B p-p65 subunits in the nuclear extracts were detected by
Western blot analysis with an anti-NF-B p-p65 subunit antibody.
Statistics. All results were expressed as means 
 standard deviations. Statis-
tical significance was determined using a Student t test for unpaired observations,
and the differences were compared to determine statistical significance by using
one-way analysis of variance, followed by Bonferroni’s post hoc test.
RESULTS
Purification of recombinant FAP and cytotoxicity. Soluble
recombinant FAP was first produced and characterized for use
in this study. Recombinant FAP was extracted after cell dis-
ruption by sonication and was purified using Ni- NTA resin.
After dialysis, the endotoxin contaminating FAP was removed,
which was confirmed by SDS-PAGE. The purified FAP had a
molecular mass of approximate 55 kDa as assessed by SDS-
PAGE (Fig. 1A). The molecular mass of FAP that was higher
than the predicted molecular mass (32 kDa) may have been
the result of the high proline content (5, 30).
There were no statistically significant differences in the per-
centages of dead cells in DC cultures exposed to up to 400
g/ml of FAP when cell death was detected by annexin V-PI
staining (Fig. 1B). This indicated that our recombinant FAP
was not cytotoxic to DCs and did not contain significant
amounts of endotoxin that would interfere with our studies
using concentrations below 400 g/ml.
FAP induces maturation of DCs. We hypothesized that DCs
are the first cells that respond to FAP during an immune
response to M. avium. To determine if FAP affects the matu-
ration of sentinel DCs to effector DCs, bone marrow-derived
DCs were cultured for 6 days in OptiMEM supplemented with
GM-CSF and IL-4 under standard conditions, followed by 1
day of growth in the presence of 100 or 200 ng/ml of FAP. LPS
were used as a positive control. The resulting populations of
DCs were analyzed by flow cytometry to determine expression
of surface molecules involved in helper T-cell activation. As
shown in Fig. 2A and 2B, FAP-treated DCs showed increased
expression of surface markers, including CD80, CD86, CD40,
MHC class I, and MHC class II. The expression of MHC class
II by FAP-treated DCs was greater than that by LPS-treated
DCs (Fig. 2B). The significant upregulation of the costimula-
tory and MHC class molecules was FAP dose dependent.
FAP induces IL-12 secretion and does not influence IL-10
production during DC maturation. Next, we determined if
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FAP-stimulated DCs could produce proinflammatory cyto-
kines that were needed to stimulate a Th response. The pri-
mary factors that drive the development of Th1 and Th2 cells
are IL-12 from APCs and IFN- or IL-4 from T cells, respec-
tively. IL-12 production was previously determined to be a
specific marker of DC activation (20). Thus, we hypothesized
that FAP-activated DCs produce IL-12. We analyzed the pro-
duction of both intracellular IL-12p40/p70 and bioactive IL-
12p70 in FAP-treated DCs using flow cytometry. As shown in
Fig. 3A, FAP treatment of DCs increased the percentage of
IL-12-positive cells compared to the results obtained for un-
treated DCs. We also investigated the production of IL-10, a
pleoiotropic cytokine known to have inhibitory effects on the
accessory functions of DCs and thereby to prevent Th re-
sponses. As expected, the levels of expression of IL-10 were
comparable for FAP-treated and untreated control DCs (Fig.
3A). These results were confirmed by performing an ELISA of
the culture supernatants, which revealed high levels of IL-
12p70 produced by DCs stimulated with FAP for 24 h (473 

12.2 pg/ml), whereas the concentration of IL-10 remained at
baseline levels (Fig. 3B). These results indicated that exposure
to FAP induces the functional maturation of DCs that produce
high levels of IL-12.
FAP reduces the endocytic activity of DCs. The expression of
surface molecules on DCs and the observed changes in IL-12
production show that exposure to FAP leads to profound in-
duction of the phenotypic maturation of DCs. We also inves-
tigated whether FAP-stimulated DCs had the reduced endo-
cytic activity characteristic of functionally mature DCs. We
exposed the DCs to FAP in the presence of dextran-FITC and
assessed the percentage of double-positive cells (CD11c and
dextran-FITC positive) by flow cytometry. The percentage of
double-positive cells was lower in the LPS-treated DC cultures
than in the untreated DCs cultures (Fig. 4). Similarly, the
percentage of double-positive cells was lower in the FAP-
treated DC cultures than in the unstimulated DC cultures (Fig.
4). Thus, the FAP-treated DCs had reduced endocytic activity,
which indicates functional maturity. Repetition of these exper-
iments at 4°C showed that the uptake of dextran-FITC by DCs
was inhibited at low temperatures.
FAP-treated DCs stimulate a Th1-type response. DCs have
the unique ability to induce a primary immune response by
stimulating naïve T cells to differentiate into active Th1 or Th2
cells. The increased expression of costimulatory and MHC
molecules by FAP-stimulated DCs enhances the presentation
of antigen to T cells and therefore should also enhance T-cell
activation. In order to determine if FAP stimulated naïve
CD4 T-cell activation by DCs, we exposed DCs to FAP for
24 h and performed an allogeneic mixed-lymphocyte reaction
analysis. CD4 splenic T cells from BALB/c mice were cocul-
tured with FAP-treated DCs derived from C57BL/6 mice. As
shown in Fig. 5A, the FAP-treated DCs elicited a higher rate
of T-cell proliferation than the untreated control DCs elicited.
Interestingly, the maturation induced by FAP stimulation pro-
foundly increased the allostimulatory capacity of the DCs.
These results demonstrate that FAP enhances the immunos-
timulatory capacity of DCs to stimulate T cells. Furthermore,
we investigated the cytokine production profile of the CD4 T
cells stimulated by FAP-treated DCs and LPS-treated DCs. As
shown in Fig. 5B, allogeneic T cells primed with FPA-treated
DCs produced a Th1 cytokine profile that included high levels
of IFN- and low levels of IL-4.
FIG. 1. FAP is not cytotoxic to DCs. (A) Recombinant FAP was produced in BL21 cells, purified with NTA resin, and subjected to SDS-PAGE.
(B) Bone marrow-derived DCs were analyzed by flow cytometry. FAP (100 to 400 ng/ml) was added on day 6, and cultures were harvested 24 h
later. The DCs were stained with anti-CD11c, annexin V, and PI. The percentage of positive cells (annexin V- and PI-stained cells) in each
quadrant is indicated. The results are representative of the results of three experiments.
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FAP activates TLR4 and MAPKs in DCs. Toll-like receptors
(TLRs) link the innate and adaptive immune responses (25).
TLR ligands include glycolipids, peptidoglycans, and LPS,
which are produced by a wide variety of microorganisms. Li-
gand binding to the TLRs activates MAPK signaling pathways
and the production of IL-12 by monocyte/macrophage lineage
cells and DCs (22). The activation of MAPKs, including
ERK1/2, c-Jun N-terminal kinases, p38 MAPK, and NF-B, is
critical for maturation of DCs (26). Recent studies suggested
that the three MAPK signaling pathways differentially regulate
all aspects of DC phenotype maturation and cytokine produc-
tion (14, 37). In order to investigate the effects of FAP on the
MAPK and NF-B signaling pathways, DCs were treated with
200 ng/ml of FAP, and kinase activation was assessed. ERK1/2
and p38 MAPK activities were measured by phospho-specific
Western blotting, and NF-B activation was indicated by nu-
FIG. 2. FAP induces the expression of costimulatory and MHC class molecules on DCs in a dose-dependent manner. DCs were cultured for
24 h in the presence of 100 or 200 ng/ml FAP and analyzed by two-color flow cytometry. The cells were gated to exclude CD11c cells. Medium,
untreated control; LPS, positive control (200 ng/ml LPS). DCs were stained with anti-CD80, anti-CD86, anti-CD40, anti-MHC class I, or anti-MHC
class II. The results are representative of the results of three experiments.
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clear translocation of the NF-B p65 subunit detected by
Western blotting. FAP induced the phosphorylation of
ERK1/2 and p38 MAPK in DCs (Fig. 6A). In addition, nuclear
translocation of the p65 subunit was observed in FAP-
treated DCs (Fig. 6B). Activation of these pathways is con-
sistent with TLR stimulation by FAP. Several bacterial pro-
teins have been suggested to enhance to the expression of
TLR4 by DCs (12, 24). Therefore, we next determined if
FAP enhanced TLR4 expression by DCs using real-time
quantitative reverse transcription-PCR. The levels of TLR4
mRNA were significantly higher in FAP-treated DCs than in
untreated control DCs (Fig. 6C). These data indicate that
FAP induced DC TLR4 expression and activation of MAPK
and NF-B pathways.
DISCUSSION
Holsti et al. (11) previously demonstrated that FAP-A-inocu-
lated mice showed stimulation of a strong T-cell response in vivo.
However, this group did not determine the effect of FAP-A on
FIG. 3. Cytokine production by FAP-treated DCs. DCs were generated by stimulating immature DCs with 200 ng/ml LPS, 100 ng/ml FAP, or
200 ng/ml FAP for 24 h. (A) Analysis of IL-12p40/p70 and IL-10 expression in CD11c DCs by intracellular cytokine staining. The percentage of
positive cells is indicated for each condition and is representative of the results of four separate experiments. (B) Analysis of IL-12p70 and IL-10
production by magnetic bead-purified DCs (1  106 cells) using ELISA. The data are the means and standard deviations of three experiments.
*, P  0.5 for a comparison with untreated DCs; **, P  0.01 for a comparison with untreated DCs. Medium, chemically untreated control group.
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the detailed mechanism of the T-cell response in vitro. Here we
report for the first time thatM. avium subsp. paratuberculosis FAP
is a highly stimulatory protein that induces a Th1 response by
stimulating DC maturation and IL-12 production.
We also provide evidence that FAP activates TLR signaling
and induces the expression of TLR by DCs. The recognition of
antigen by TLRs leads to activation of MAPK and NF-B path-
ways in DCs (6, 10, 13, 16). Consistent with this finding, FAP was
able to activate both MAPK and NF-B pathways in DCs. NF-B
activation is essential for the expression of a variety of the proin-
flammatory cytokines (9). Therefore, the activation of NF-B by
FAP is a possible mechanism underlying the increased expression
of IL-12 by DCs. Together, our results suggest that FAP binds to
a TLR on DCs and elicits MAPK- and NF-B-mediated IL-12
production. This IL-12 production is then responsible for activat-
ing CD4-positive T cells to differentiate into Th1 cells that pro-
duce IFN-. IL-23, a more recently discovered member of the
IL-12 family, also promotes a Th1 response, but it has functions
distinct from those of IL-12. IL-23 is a heterodimeric cytokine
composed of the p19 and p40 subunits. While the p19 subunit is
unique to IL-23, p40 is shared with IL-12 (23). IL-23 is required
for the generation of effector memory T cells and is also needed
for generation of IL-17-producing T cells, which play an impor-
tant role in the inflammatory response (1, 23). Through these
activities, IL-23 plays a critical role in chronic inflammatory dis-
eases.
FIG. 4. FAP-treated DCs have reduced endocytic capacity. DCs were treated with 200 ng/ml FAP or LPS for 24 h and stained with a
PE-conjugated anti-CD11c antibody. Endocytic activity at 37°C or 4°C was assessed by flow cytometry analysis of dextran-FITC uptake. The
percentages of dextran-FITC-positive CD11c-positive cells are indicated. The results are representative of the results of four experiments.
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Recently, Lei et al. (15) suggested that M. avium can infect
bovine DCs and does not induce strong DC antigen presenta-
tion. In addition, M. avium-infected DCs produce a small
amount of the IL-12 cytokine but a large amount of the IL-10
cytokine. The greater IL-10 cytokine production may inhibit
not only DC maturation and initiation of Th1 polarization but
also bystander macrophage activation at the infection site (15).
In this way, FAP forms a link between the innate DC re-
sponse and the adaptive Th1 immune response to M. avium.
The nature of the bacterial pathogens that are encountered by
the adaptive immune response tailors the balance of the Th1/
Th2 response to a particular pathogen. Our results show that
M. avium FAP activates DCs and specifically produces a Th1
immune response ex vivo. FAP induces Th1 polarization by
increasing IL-12 production by DCs and IFN- production by
T cells. However, it is possible that FAP, like the chlamydial
major outer membrane protein antigen (MOMP), may elicit a
different T-cell response in vivo. MOMP also induces CD4
Th1 polarization in vivo, but DCs pulsed ex vivo with MOMP
and adoptively transferred into naïve mice generate a Th2
immune response (32). Another bacterial protein, PorA of
Neisseria meningitidis, also directs differentiation of CD4 T
cells toward a Th2-type response (2). Together, previous
studies of the role of FAP in immune responses to myco-
bacteria have shown that the presentation of FAP peptide
by M. avium-infected macrophages to T cells contributes to
the development of protective immunity to this pathogen
(11). Thus, it is critical to extend the study of FAP antige-
nicity to in vivo studies to fully understand the immune
response to M. avium.
FIG. 5. FAP-treated DCs induce proliferation of CD4 T cells and a Th1 response. The DCs were incubated for 24 h in medium with phorbol
myristate acetate (positive control), 100 ng/ml FAP, 200 ng/ml FAP, or 200 ng/ml LPS. The DCs were then washed and cocultured with allogeneic T cells
for 3 days. (A) Percentage of T-cell proliferation as determined by CFSE flow cytometry. (B) Results for cells examined for cytokine release after 48 h.
IL-4 and IFN- concentrations in culture supernatants were measured by ELISA. The data are expressed as pg/ml/106 cells (means and standard
deviations for triplicate cultures). *, P 0.05, and **, P 0.01, for a comparison with T cells primed with untreated DCs. Medium, chemically untreated
control group.
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FIG. 6. FAP enhanced TLR4 expression, MAPK activation, and NF-B nuclear translocation. DCs were treated with 200 ng/ml FAP for 15,
30, or 45 min. (A) Cell lysates were prepared and blotted with anti-phospho-ERK1/2, anti-ERK1/2, anti-phosopho-p38, and anti-p38 antibody.
(B) Nuclear extracts were blotted with anti-phosphop-p65 antibody. A signal was detected with biotinylated goat anti-rabbit IgG and visualized
using enhanced chemiluminescence. (C) Total RNA was extracted, and quantitative real-time PCR was performed using sequence-specific primers
for TLR4 and glyceraldehyde-3-phosphate dehydrogenase. Glyceraldehyde-3-phosphate dehydrogenase was included as an internal control.
Medium, untreated DC group. For each sample, CT (ddCT; crossing point) values were calculated as the CT for the target gene minus the CT
for the glyceraldehyde-3-phosphate dehydrogenase gene. Gene expression was derived according to the equation 2CT; changes in gene
expression were expressed relative to basal levels. **, P  0.01 for the comparison with the medium control. The data are the means and standard
deviations of three experiments.
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In summary, we demonstrated that FAP is a potent antigen
and initiates a specific Th1 immune response in vitro. There-
fore, FAP, in addition to the known M. avium antigen LPS,
may play key roles in determining the nature of the immune
response against M. avium subsp. paratuberculosis. Further un-
derstanding of the mechanism by which FAP modulates DC
function may lead to development of effective M. avium subsp.
paratuberculosis vaccines and an effective immunotherapy ad-
juvant for other infectious diseases.
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